Benznidazole self-emulsifying delivery system: A novel alternative dosage form for Chagas disease treatment-Reference-Cited by-同舟云学术

Benznidazole self-emulsifying delivery system: A novel alternative dosage form for Chagas disease treatment

Published:2020-03 Issue: Volume:145 Page:105234
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Mazzeti Ana Lia,Oliveira Liliam Teixeira,Gonçalves Karolina R.,Schaun Géssica C.,Mosqueira Vanessa Carla Furtado^ORCID,Bahia Maria Terezinha

Funder

NANOBIOMG-Network

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference50 articles.

1. Formulation of solid self-nanoemulsifying drug delivery systems using n -methyl pyrrolidone as cosolvent;Agrawal;Drug. Dev. Ind. Pharm,2015

2. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability;Amidon;Pharm. Res.,1995

3. I Diretriz Latino-Americana para o diagnóstico e tratamento da cardiopatia chagásica: resumo executivo;Andrade;Arq. Bras. Cardiol.,2011

4. Formulation and Evaluation of Solid Self-Micro Emulsifying Drug Delivery System for Improved Oral Delivery of Olmesartan Medoxomil;Bakhle;Int J Pharm Sci Res,2015

5. Do drug release studies from SEDDS make any sense?;Bernkop-Schnürch;J. Control. Release,2018

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Organic solvent-free benznidazole nanosuspension as an approach to a novel pediatric formulation for Chagas disease;Therapeutic Delivery;2024-08-05

2. Supramolecular eutectogel as new oral paediatric delivery system to enhance benznidazole bioavailability;International Journal of Pharmaceutics;2024-08

3. Drugs in preclinical and early clinical development for the treatment of Chagas´s disease: the current status;Expert Opinion on Investigational Drugs;2024-05-14

4. New drug discovery strategies for the treatment of benznidazole-resistance in Trypanosoma cruzi , the causative agent of Chagas disease;Expert Opinion on Drug Discovery;2024-05-07

5. Combination of the Topical Photodynamic Therapy of Chloroaluminum Phthalocyanine Liposomes with Fexinidazole Oral Self-Emulsifying System as a New Strategy for Cutaneous Leishmaniasis Treatment;Pharmaceutics;2024-04-07